Toggle menu
+31 20 808 0893

CabozAntinib Free Base | Gentaur

€340.00
(No reviews yet) Write a Review
SKU:
111-C8901-50-GEN
Availability:
IN STOCK
Size:
100 µg
Adding to cart… category.add_cart_announcement

Product Description

CabozAntinib Free Base

Description:

 Cabozantinib, also known as XL-184 or BMS-907351, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Cabozantinib strongly binds to and inhibits several tyrosine receptor kinases. Specifically, cabozantinib appears to have a strong affinity for the hepatocyte growth factor receptor (Met) and vascular endothelial growth factor receptor 2 (VEGFR2), which may result in inhibition of tumor growth and angiogenesis, and tumor regression. Cabozantinib was approved by the U.S. FDA in November 2012 for the treatment of medullary thyroid cancer.

Appearance:

white solid powder

Purity:

>98% (or refer to the Certificate of Analysis)

Storage Condition:

 Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:

Soluble in DMSO, not in water

 

Product Videos

Custom Field

Size 100 µg

Product Reviews

Write a Review